Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 4, 2022--
The "Clinical Trials Outsourcing Market Share, Size, Trends, Industry Analysis Report, By End-Use, By Therapeutics Area, By Workflow, By Region, Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global clinical trials outsourcing market size is expected to reach USD 67.62 billion by 2030, according to a new study. The report " gives a detailed insight into current market dynamics and provides analysis on future market growth.
Pharmaceutical and biotechnology businesses outsource clinical trials because they lack the requisite resources, experience, and time. Clinical trial outsourcing includes advantages such as lower costs, shorter turnaround times, and better results. Most clinical trials are contracted out to suppliers and contract research organisations.
The active pharmaceutical ingredients are used to create dosage forms, which are often created remotely from the locations where tablets, suspensions, and liquids are formed. As a result, more companies are outsourcing the manufacturing of API to countries with affordable labour. These factors contribute to the market need for clinical trials outsourcing on a global scale.
In the past decade, multinational pharmaceutical businesses have successfully established a variety of sourcing methods and service lines in emerging markets, either through local affiliates or service providers. Although these regions were originally given the task of hosting clinical trials in order to take advantage of their substantial patient population, developing markets now provide a wide range of highly qualified people that can support the entire clinical trial process programming, for example. In addition to data processing, scientific research, biostatistics, and regulatory operations were soon added to the list of activities that were outsourced.
Clinical trials conducted on-site have been disrupted globally as a result of the COVID-19 epidemic. During this time, there was a major overhaul of the healthcare sector. As a response, regulatory bodies all over the world have launched a range of initiatives targeted at accelerating clinical trials in order to find novel remedies.
Positive growth in demand for outsourced clinical trials was influenced by COVID-19. Numerous sectors, notably the healthcare sector, witnessed major transformation, and during COVID-19, small and medium-sized biotech enterprises were on the edge of closing permanently.
Clinical Trials Outsourcing Market Report Highlights
The publisher has segmented the clinical trials outsourcing market report based on workflow, therapeutic area, end-use, and region:
Clinical Trials Outsourcing, Workflow Outlook (Revenue - USD Billion, 2018 - 2030)
Clinical Trials Outsourcing, Therapeutics area Outlook (Revenue - USD Billion, 2018 - 2030)
Clinical Trials Outsourcing, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Clinical Trials Outsourcing, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Global Clinical Trials Outsourcing Market Insights
5. Global Clinical Trials Outsourcing Market, by Workflow
6. Global Clinical Trials Outsourcing Market, by Therapeutics Area
7. Global Clinical Trials Outsourcing Market, by End-Use
8. Global Clinical Trials Outsourcing Market, by Geography
9. Competitive Landscape
10. Company Profiles
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/p6miuw
View source version on businesswire.com:https://www.businesswire.com/news/home/20221104005484/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: PROFESSIONAL SERVICES HEALTH CLINICAL TRIALS PHARMACEUTICAL OUTSOURCING BUSINESS BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/04/2022 11:27 AM/DISC: 11/04/2022 11:27 AM
http://www.businesswire.com/news/home/20221104005484/en